{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T03:57:31Z","timestamp":1791863851861,"version":"4.3.4"},"reference-count":72,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T00:00:00Z","timestamp":1646611200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172301"],"award-info":[{"award-number":["82172301"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Immunol Immunother"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1007\/s00262-022-03167-8","type":"journal-article","created":{"date-parts":[[2022,3,7]],"date-time":"2022-03-07T08:04:33Z","timestamp":1646640273000},"page":"2449-2467","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":29,"title":["Comprehensive analyses of prognostic biomarkers and immune infiltrates among histone lysine demethylases (KDMs) in hepatocellular carcinoma"],"prefix":"10.1007","volume":"71","author":[{"given":"Li-Hua","family":"Qu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui-Mei","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang-Bo","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Zhan","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Bing","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2787-5694","authenticated-orcid":false,"given":"Hui-Fen","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,3,7]]},"reference":[{"key":"3167_CR1","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/nature16969","volume":"531","author":"C Ma","year":"2016","unstructured":"Ma C, Kesarwala AH, Eggert T, Medina-Echeverz J, Kleiner DE, Jin P, Stroncek DF, Terabe M, Kapoor V, ElGindi M et al (2016) NAFLD causes selective CD4(+) T lymphocyte loss and promotes hepatocarcinogenesis. Nature 531:253\u2013257","journal-title":"Nature"},{"key":"3167_CR2","doi-asserted-by":"crossref","unstructured":"Kanda T, Goto T, Hirotsu Y, Moriyama M, Omata M (2019) Molecular mechanisms driving progression of liver cirrhosis towards hepatocellular carcinoma in Chronic Hepatitis B and C infections: a review. Int J Mol Sci, 20.","DOI":"10.3390\/ijms20061358"},{"key":"3167_CR3","doi-asserted-by":"publisher","first-page":"11","DOI":"10.3322\/caac.21166","volume":"63","author":"R Siegel","year":"2013","unstructured":"Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11\u201330","journal-title":"CA Cancer J Clin"},{"issue":"Suppl 1","key":"3167_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/hep.31288","volume":"73","author":"KA McGlynn","year":"2021","unstructured":"McGlynn KA, Petrick JL, El-Serag HB (2021) Epidemiology of hepatocellular carcinoma. Hepatology 73(Suppl 1):4\u201313","journal-title":"Hepatology"},{"key":"3167_CR5","doi-asserted-by":"crossref","unstructured":"Wang F, Malnassy G, Qiu W (2021) The epigenetic regulation of microenvironment in hepatocellular carcinoma. Front Oncol 11:653037.","DOI":"10.3389\/fonc.2021.653037"},{"key":"3167_CR6","doi-asserted-by":"publisher","first-page":"9593254","DOI":"10.1155\/2020\/9593254","volume":"2020","author":"MH Yousef","year":"2020","unstructured":"Yousef MH, El-Fawal HAN, Abdelnaser A (2020) Hepigenetics: a review of epigenetic modulators and potential therapies in hepatocellular carcinoma. Biomed Res Int 2020:9593254","journal-title":"Biomed Res Int"},{"key":"3167_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1038\/s41580-019-0204-5","volume":"21","author":"W Zhang","year":"2020","unstructured":"Zhang W, Qu J, Liu GH, Belmonte JCI (2020) The ageing epigenome and its rejuvenation. Nat Rev Mol Cell Biol 21:137\u2013150","journal-title":"Nat Rev Mol Cell Biol"},{"key":"3167_CR8","doi-asserted-by":"crossref","unstructured":"Audia JE, Campbell RM (2016) Histone modifications and cancer. Cold Spring Harb Perspect Biol 8:a019521.","DOI":"10.1101\/cshperspect.a019521"},{"key":"3167_CR9","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.csbj.2018.06.001","volume":"16","author":"Y Chen","year":"2018","unstructured":"Chen Y, Liu X, Li Y, Quan C, Zheng L, Huang K (2018) Lung cancer therapy targeting histone methylation: opportunities and challenges. Comput Struct Biotechnol J 16:211\u2013223","journal-title":"Comput Struct Biotechnol J"},{"key":"3167_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.critrevonc.2012.11.008","volume":"86","author":"E Paolicchi","year":"2013","unstructured":"Paolicchi E, Crea F, Farrar WL, Green JE, Danesi R (2013) Histone lysine demethylases in breast cancer. Crit Rev Oncol Hematol 86:97\u2013103","journal-title":"Crit Rev Oncol Hematol"},{"key":"3167_CR11","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1073\/pnas.1009933108","volume":"108","author":"ME McLaughlin-Drubin","year":"2011","unstructured":"McLaughlin-Drubin ME, Crum CP, Munger K (2011) Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming. Proc Natl Acad Sci U S A 108:2130\u20132135","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3167_CR12","doi-asserted-by":"crossref","unstructured":"Lin Q, Wu Z, Yue X, Yu X, Wang Z, Song X, Xu L, He Y, Ge Y, Tan S et al (2020) ZHX2 restricts hepatocellular carcinoma by suppressing stem cell-like traits through KDM2A-mediated H3K36 demethylation. EBioMedicine 53:102676.","DOI":"10.1016\/j.ebiom.2020.102676"},{"key":"3167_CR13","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1158\/0008-5472.CAN-14-1560","volume":"75","author":"A Sakamoto","year":"2015","unstructured":"Sakamoto A, Hino S, Nagaoka K, Anan K, Takase R, Matsumori H, Ojima H, Kanai Y, Arita K, Nakao M (2015) Lysine demethylase LSD1 coordinates glycolytic and mitochondrial metabolism in hepatocellular carcinoma cells. Cancer Res 75:1445\u20131456","journal-title":"Cancer Res"},{"key":"3167_CR14","doi-asserted-by":"publisher","first-page":"6262","DOI":"10.1038\/onc.2017.222","volume":"36","author":"T Nakatsuka","year":"2017","unstructured":"Nakatsuka T, Tateishi K, Kudo Y, Yamamoto K, Nakagawa H, Fujiwara H, Takahashi R, Miyabayashi K, Asaoka Y, Tanaka Y et al (2017) Impact of histone demethylase KDM3A-dependent AP-1 transactivity on hepatotumorigenesis induced by PI3K activation. Oncogene 36:6262\u20136271","journal-title":"Oncogene"},{"key":"3167_CR15","doi-asserted-by":"publisher","first-page":"6847","DOI":"10.18632\/oncotarget.6867","volume":"7","author":"BH Wu","year":"2016","unstructured":"Wu BH, Chen H, Cai CM, Fang JZ, Wu CC, Huang LY, Wang L, Han ZG (2016) Epigenetic silencing of JMJD5 promotes the proliferation of hepatocellular carcinoma cells by down-regulating the transcription of CDKN1A 686. Oncotarget 7:6847\u20136863","journal-title":"Oncotarget"},{"key":"3167_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","volume":"6","author":"DR Rhodes","year":"2004","unstructured":"Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, Ghosh D, Barrette T, Pandey A, Chinnaiyan AM (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6:1\u20136","journal-title":"Neoplasia"},{"key":"3167_CR17","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang Z, Li C, Kang B, Gao G, Li C, Zhang Z (2017) GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res 45:W98\u2013W102","journal-title":"Nucleic Acids Res"},{"key":"3167_CR18","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","volume":"19","author":"DS Chandrashekar","year":"2017","unstructured":"Chandrashekar DS, Bashel B, Balasubramanya SAH, Creighton CJ, Ponce-Rodriguez I, Chakravarthi B, Varambally S (2017) UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses. Neoplasia 19:649\u2013658","journal-title":"Neoplasia"},{"key":"3167_CR19","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E et al (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2:401\u2013404","journal-title":"Cancer Discov"},{"key":"3167_CR20","doi-asserted-by":"crossref","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E et al (2013) Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal 6:pl1.","DOI":"10.1126\/scisignal.2004088"},{"key":"3167_CR21","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT et al (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38:W214-220","journal-title":"Nucleic Acids Res"},{"key":"3167_CR22","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk D, Gable AL, Lyon D, Junge A, Wyder S, Huerta-Cepas J, Simonovic M, Doncheva NT, Morris JH, Bork P et al (2019) STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res 47:D607\u2013D613","journal-title":"Nucleic Acids Res"},{"key":"3167_CR23","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/nprot.2008.211","volume":"4","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA (2009) Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44\u201357","journal-title":"Nat Protoc"},{"key":"3167_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/nar\/gkn923","volume":"37","author":"W da Huang","year":"2009","unstructured":"da Huang W, Sherman BT, Lempicki RA (2009) Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res 37:1\u201313","journal-title":"Nucleic Acids Res"},{"key":"3167_CR25","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, Benner C, Chanda SK (2019) Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun 10:1523","journal-title":"Nat Commun"},{"key":"3167_CR26","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545\u201315550","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3167_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF, Subramanian A, Sihag S, Lehar J, Puigserver P, Carlsson E, Ridderstrale M, Laurila E et al (2003) PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267\u2013273","journal-title":"Nat Genet"},{"key":"3167_CR28","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, Li B, Liu XS (2017) TIMER: A web server for comprehensive analysis of tumor-infiltrating immune cells. Cancer Res 77:e108\u2013e110","journal-title":"Cancer Res"},{"key":"3167_CR29","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J, Jiang P, Shen H, Aster JC, Rodig S et al (2016) Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol 17:174","journal-title":"Genome Biol"},{"key":"3167_CR30","doi-asserted-by":"publisher","first-page":"85","DOI":"10.2119\/molmed.2008.00110","volume":"15","author":"VR Mas","year":"2009","unstructured":"Mas VR, Maluf DG, Archer KJ, Yanek K, Kong X, Kulik L, Freise CE, Olthoff KM, Ghobrial RM, McIver P, Fisher R (2009) Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma. Mol Med 15:85\u201394","journal-title":"Mol Med"},{"key":"3167_CR31","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1002\/hep.21622","volume":"45","author":"E Wurmbach","year":"2007","unstructured":"Wurmbach E, Chen YB, Khitrov G, Zhang W, Roayaie S, Schwartz M, Fiel I, Thung S, Mazzaferro V, Bruix J et al (2007) Genome-wide molecular profiles of HCV-induced dysplasia and hepatocellular carcinoma. Hepatology 45:938\u2013947","journal-title":"Hepatology"},{"key":"3167_CR32","doi-asserted-by":"publisher","first-page":"10202","DOI":"10.1158\/0008-5472.CAN-10-2607","volume":"70","author":"S Roessler","year":"2010","unstructured":"Roessler S, Jia HL, Budhu A, Forgues M, Ye QH, Lee JS, Thorgeirsson SS, Sun Z, Tang ZY, Qin LX, Wang XW (2010) a unique metastasis gene signature enables prediction of tumor relapse in early-stage hepatocellular carcinoma patients. Cancer Res 70:10202\u201310212","journal-title":"Cancer Res"},{"key":"3167_CR33","doi-asserted-by":"publisher","first-page":"1929","DOI":"10.1091\/mbc.02-02-0023","volume":"13","author":"X Chen","year":"2002","unstructured":"Chen X, Cheung ST, So S, Fan ST, Barry C, Higgins J, Lai KM, Ji J, Dudoit S, Ng IO et al (2002) Gene expression patterns in human liver cancers. Mol Biol Cell 13:1929\u20131939","journal-title":"Mol Biol Cell"},{"key":"3167_CR34","doi-asserted-by":"publisher","first-page":"3034","DOI":"10.1158\/0008-5472.CAN-09-2823","volume":"70","author":"HG Woo","year":"2010","unstructured":"Woo HG, Lee JH, Yoon JH, Kim CY, Lee HS, Jang JJ, Yi NJ, Suh KS, Lee KU, Park ES et al (2010) Identification of a cholangiocarcinoma-like gene expression trait in hepatocellular carcinoma. Cancer Res 70:3034\u20133041","journal-title":"Cancer Res"},{"key":"3167_CR35","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1056\/NEJMra1805035","volume":"383","author":"SE Bates","year":"2020","unstructured":"Bates SE (2020) Epigenetic Therapies for cancer. N Engl J Med 383:650\u2013663","journal-title":"N Engl J Med"},{"key":"3167_CR36","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/j.molcel.2012.11.006","volume":"48","author":"JC Black","year":"2012","unstructured":"Black JC, Van Rechem C, Whetstine JR (2012) Histone lysine methylation dynamics: establishment, regulation, and biological impact. Mol Cell 48:491\u2013507","journal-title":"Mol Cell"},{"key":"3167_CR37","doi-asserted-by":"crossref","unstructured":"Sterling J, Menezes SV, Abbassi RH, Munoz L (2020) Histone lysine demethylases and their functions in cancer. Int J Cancer.","DOI":"10.1002\/ijc.33375"},{"key":"3167_CR38","doi-asserted-by":"crossref","unstructured":"Kim S, Bolatkan A, Kaneko S, Ikawa N, Asada K, Komatsu M, Hayami S, Ojima H, Abe N, Yamaue H, Hamamoto R (2019) Deregulation of the histone lysine-specific demethylase 1 is involved in human hepatocellular carcinoma. Biomolecules, p 9.","DOI":"10.3390\/biom9120810"},{"key":"3167_CR39","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1016\/j.cell.2004.12.012","volume":"119","author":"Y Shi","year":"2004","unstructured":"Shi Y, Lan F, Matson C, Mulligan P, Whetstine JR, Cole PA, Casero RA, Shi Y (2004) Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell 119:941\u2013953","journal-title":"Cell"},{"key":"3167_CR40","doi-asserted-by":"publisher","first-page":"10662","DOI":"10.1038\/s41598-017-11106-2","volume":"7","author":"T Khanal","year":"2017","unstructured":"Khanal T, Choi K, Leung YK, Wang J, Kim D, Janakiram V, Cho SG, Puga A, Ho SM, Kim K (2017) Loss of NR2E3 represses AHR by LSD1 reprogramming, is associated with poor prognosis in liver cancer. Sci Rep 7:10662","journal-title":"Sci Rep"},{"key":"3167_CR41","doi-asserted-by":"publisher","first-page":"5808","DOI":"10.1158\/0008-5472.CAN-18-0340","volume":"78","author":"L Gu","year":"2018","unstructured":"Gu L, Zhu Y, Lin X, Li Y, Cui K, Prochownik EV, Li Y (2018) Amplification of glyceronephosphate O-acyltransferase and recruitment of USP30 stabilize DRP1 to promote hepatocarcinogenesis. Cancer Res 78:5808\u20135819","journal-title":"Cancer Res"},{"key":"3167_CR42","doi-asserted-by":"crossref","unstructured":"Hu B, Xu Y, Li YC, Huang JF, Cheng JW, Guo W, Yin Y, Gao Y, Wang PX, Wu SY et al (2020) CD13 promotes hepatocellular carcinogenesis and sorafenib resistance by activating HDAC5-LSD1-NF-\u03baB oncogenic signaling. Clin Transl Med 10:e233.","DOI":"10.1002\/ctm2.233"},{"key":"3167_CR43","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1128\/MCB.01404-14","volume":"35","author":"K Nagaoka","year":"2015","unstructured":"Nagaoka K, Hino S, Sakamoto A, Anan K, Takase R, Umehara T, Yokoyama S, Sasaki Y, Nakao M (2015) Lysine-specific demethylase 2 suppresses lipid influx and metabolism in hepatic cells. Mol Cell Biol 35:1068\u20131080","journal-title":"Mol Cell Biol"},{"key":"3167_CR44","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1002\/jcp.27080","volume":"234","author":"R Ou","year":"2019","unstructured":"Ou R, Zhu L, Zhao L, Li W, Tao F, Lu Y, He Q, Li J, Ren Y, Xu Y (2019) HPV16 E7-induced upregulation of KDM2A promotes cervical cancer progression by regulating miR-132-radixin pathway. J Cell Physiol 234:2659\u20132671","journal-title":"J Cell Physiol"},{"key":"3167_CR45","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13046-019-1489-0","volume":"39","author":"M Quan","year":"2020","unstructured":"Quan M, Chen Z, Jiao F, Xiao X, Xia Q, Chen J, Chao Q, Li Y, Gao Y, Yang H et al (2020) Lysine demethylase 2 (KDM2B) regulates hippo pathway via MOB1 to promote pancreatic ductal adenocarcinoma (PDAC) progression. J Exp Clin Cancer Res 39:13","journal-title":"J Exp Clin Cancer Res"},{"key":"3167_CR46","doi-asserted-by":"publisher","first-page":"3935","DOI":"10.1158\/0008-5472.CAN-13-2733","volume":"74","author":"F Kottakis","year":"2014","unstructured":"Kottakis F, Foltopoulou P, Sanidas I, Keller P, Wronski A, Dake BT, Ezell SA, Shen Z, Naber SP, Hinds PW et al (2014) NDY1\/KDM2B functions as a master regulator of polycomb complexes and controls self-renewal of breast cancer stem cells. Cancer Res 74:3935\u20133946","journal-title":"Cancer Res"},{"key":"3167_CR47","doi-asserted-by":"publisher","first-page":"835","DOI":"10.2217\/epi-2018-0195","volume":"11","author":"A Astolfi","year":"2019","unstructured":"Astolfi A, Fiore M, Melchionda F, Indio V, Bertuccio SN, Pession A (2019) BCOR involvement in cancer. Epigenomics 11:835\u2013855","journal-title":"Epigenomics"},{"key":"3167_CR48","doi-asserted-by":"crossref","unstructured":"Dandawate P, Ghosh C, Palaniyandi K, Paul S, Rawal S, Pradhan R, Sayed AAA, Choudhury S, Standing D, Subramaniam D et al (2019) The histone demethylase KDM3A, increased in human pancreatic tumors, regulates expression of DCLK1 and promotes tumorigenesis in mice. Gastroenterology 157:1646\u20131659 e1611.","DOI":"10.1053\/j.gastro.2019.08.018"},{"key":"3167_CR49","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1158\/1541-7786.MCR-20-0404","volume":"19","author":"Y Sui","year":"2021","unstructured":"Sui Y, Gu R, Janknecht R (2021) Crucial functions of the JMJD1\/KDM3 epigenetic regulators in cancer. Mol Cancer Res 19:3\u201313","journal-title":"Mol Cancer Res"},{"key":"3167_CR50","doi-asserted-by":"crossref","unstructured":"Zhang Y, Pan Q, Shao Z (2020) Tumor-suppressive role of microRNA-202\u20133p in Hepatocellular carcinoma through the KDM3A\/HOXA1\/MEIS3 Pathway. Front Cell Dev Biol 8:556004.","DOI":"10.3389\/fcell.2020.556004"},{"key":"3167_CR51","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.bbrc.2018.11.179","volume":"508","author":"MJ An","year":"2019","unstructured":"An MJ, Kim DH, Kim CH, Kim M, Rhee S, Seo SB, Kim JW (2019) Histone demethylase KDM3B regulates the transcriptional network of cell-cycle genes in hepatocarcinoma HepG2 cells. Biochem Biophys Res Commun 508:576\u2013582","journal-title":"Biochem Biophys Res Commun"},{"key":"3167_CR52","doi-asserted-by":"publisher","first-page":"3200","DOI":"10.1158\/0008-5472.CAN-20-3317","volume":"81","author":"A Bhan","year":"2021","unstructured":"Bhan A, Ansari KI, Chen MY, Jandial R (2021) Inhibition of Jumonji histone demethylases selectively suppresses HER2(+) breast leptomeningeal carcinomatosis growth via inhibition of GMCSF expression. Cancer Res 81:3200\u20133214","journal-title":"Cancer Res"},{"key":"3167_CR53","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1038\/s41419-021-03738-0","volume":"12","author":"ME Massett","year":"2021","unstructured":"Massett ME, Monaghan L, Patterson S, Mannion N, Bunschoten RP, Hoose A, Marmiroli S, Liskamp RMJ, Jorgensen HG, Vetrie D et al (2021) A KDM4A-PAF1-mediated epigenomic network is essential for acute myeloid leukemia cell self-renewal and survival. Cell Death Dis 12:573","journal-title":"Cell Death Dis"},{"key":"3167_CR54","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1038\/s41419-020-03019-2","volume":"11","author":"G Ding","year":"2020","unstructured":"Ding G, Xu X, Li D, Chen Y, Wang W, Ping D, Jia S, Cao L (2020) Fisetin inhibits proliferation of pancreatic adenocarcinoma by inducing DNA damage via RFXAP\/KDM4A-dependent histone H3K36 demethylation. Cell Death Dis 11:893","journal-title":"Cell Death Dis"},{"key":"3167_CR55","doi-asserted-by":"publisher","first-page":"14538","DOI":"10.1038\/s41598-020-71403-1","volume":"10","author":"DB Chen","year":"2020","unstructured":"Chen DB, Xie XW, Zhao YJ, Wang XY, Liao WJ, Chen P, Deng KJ, Fei R, Qin WY, Wang JH et al (2020) RFX5 promotes the progression of hepatocellular carcinoma through transcriptional activation of KDM4A. Sci Rep 10:14538","journal-title":"Sci Rep"},{"key":"3167_CR56","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1111\/jcmm.15030","volume":"24","author":"Y Yang","year":"2020","unstructured":"Yang Y, Song S, Meng Q, Wang L, Li X, Xie S, Chen Y, Jiang X, Wang C, Lu Y et al (2020) miR24-2 accelerates progression of liver cancer cells by activating Pim1 through tri-methylation of Histone H3 on the ninth lysine. J Cell Mol Med 24:2772\u20132790","journal-title":"J Cell Mol Med"},{"key":"3167_CR57","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1002\/ijc.31881","volume":"144","author":"J Plch","year":"2019","unstructured":"Plch J, Hrabeta J, Eckschlager T (2019) KDM5 demethylases and their role in cancer cell chemoresistance. Int J Cancer 144:221\u2013231","journal-title":"Int J Cancer"},{"key":"3167_CR58","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/s13046-020-01735-3","volume":"39","author":"C Du","year":"2020","unstructured":"Du C, Lv C, Feng Y, Yu S (2020) Activation of the KDM5A\/miRNA-495\/YTHDF2\/m6A-MOB3B axis facilitates prostate cancer progression. J Exp Clin Cancer Res 39:223","journal-title":"J Exp Clin Cancer Res"},{"key":"3167_CR59","doi-asserted-by":"publisher","first-page":"4040","DOI":"10.1111\/jcmm.16371","volume":"25","author":"YS Ma","year":"2021","unstructured":"Ma YS, Wu TM, Qian B, Liu YS, Ding H, Fan MM, Liu JB, Yu F, Wang HM, Shi Y et al (2021) KDM5A silencing transcriptionally suppresses the FXYD3-PI3K\/AKT axis to inhibit angiogenesis in hepatocellular cancer via miR-433 up-regulation. J Cell Mol Med 25:4040\u20134052","journal-title":"J Cell Mol Med"},{"key":"3167_CR60","doi-asserted-by":"crossref","unstructured":"Guo JC, Liu Z, Yang YJ, Guo M, Zhang JQ, Zheng JF (2021) KDM5B promotes self-renewal of hepatocellular carcinoma cells through the microRNA-448-mediated YTHDF3\/ITGA6 axis. J Cell Mol Med.","DOI":"10.1111\/jcmm.16342"},{"key":"3167_CR61","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s13046-016-0311-5","volume":"35","author":"D Wang","year":"2016","unstructured":"Wang D, Han S, Peng R, Jiao C, Wang X, Yang X, Yang R, Li X (2016) Depletion of histone demethylase KDM5B inhibits cell proliferation of hepatocellular carcinoma by regulation of cell cycle checkpoint proteins p15 and p27. J Exp Clin Cancer Res 35:37","journal-title":"J Exp Clin Cancer Res"},{"key":"3167_CR62","first-page":"1","volume":"51","author":"S Chang","year":"2019","unstructured":"Chang S, Yim S, Park H (2019) The cancer driver genes IDH1\/2, JARID1C\/ KDM5C, and UTX\/ KDM6A: crosstalk between histone demethylation and hypoxic reprogramming in cancer metabolism. Exp Mol Med 51:1\u201317","journal-title":"Exp Mol Med"},{"key":"3167_CR63","doi-asserted-by":"publisher","first-page":"E3384","DOI":"10.1073\/pnas.1606876113","volume":"113","author":"T Kodama","year":"2016","unstructured":"Kodama T, Newberg JY, Kodama M, Rangel R, Yoshihara K, Tien JC, Parsons PH, Wu H, Finegold MJ, Copeland NG, Jenkins NA (2016) Transposon mutagenesis identifies genes and cellular processes driving epithelial-mesenchymal transition in hepatocellular carcinoma. Proc Natl Acad Sci U S A 113:E3384-3393","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3167_CR64","doi-asserted-by":"publisher","first-page":"6520","DOI":"10.1158\/0008-5472.CAN-15-3029","volume":"76","author":"B Tang","year":"2016","unstructured":"Tang B, Qi G, Tang F, Yuan S, Wang Z, Liang X, Li B, Yu S, Liu J, Huang Q et al (2016) Aberrant JMJD3 expression upregulates slug to promote migration, invasion, and stem cell-like behaviors in hepatocellular carcinoma. Cancer Res 76:6520\u20136532","journal-title":"Cancer Res"},{"key":"3167_CR65","doi-asserted-by":"publisher","first-page":"6399","DOI":"10.1002\/cam4.3285","volume":"9","author":"L Li","year":"2020","unstructured":"Li L, Liu JD, Gao GD, Zhang K, Song YW, Li HB (2020) Puerarin 6\u2033-O-xyloside suppressed HCC via regulating proliferation, stemness, and apoptosis with inhibited PI3K\/AKT\/mTOR. Cancer Med 9:6399\u20136410","journal-title":"Cancer Med"},{"key":"3167_CR66","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1101\/gad.510809","volume":"23","author":"K Agger","year":"2009","unstructured":"Agger K, Cloos PA, Rudkjaer L, Williams K, Andersen G, Christensen J, Helin K (2009) The H3K27me3 demethylase JMJD3 contributes to the activation of the INK4A-ARF locus in response to oncogene- and stress-induced senescence. Genes Dev 23:1171\u20131176","journal-title":"Genes Dev"},{"key":"3167_CR67","doi-asserted-by":"publisher","first-page":"2849","DOI":"10.1002\/ijc.31843","volume":"143","author":"KH Lee","year":"2018","unstructured":"Lee KH, Hong S, Kang M, Jeong CW, Ku JH, Kim HH, Kwak C (2018) Histone demethylase KDM7A controls androgen receptor activity and tumor growth in prostate cancer. Int J Cancer 143:2849\u20132861","journal-title":"Int J Cancer"},{"key":"3167_CR68","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1002\/jcp.29008","volume":"235","author":"Z Meng","year":"2020","unstructured":"Meng Z, Liu Y, Wang J, Fan H, Fang H, Li S, Yuan L, Liu C, Peng Y, Zhao W et al (2020) Histone demethylase KDM7A is required for stem cell maintenance and apoptosis inhibition in breast cancer. J Cell Physiol 235:932\u2013943","journal-title":"J Cell Physiol"},{"key":"3167_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/s41388-018-0414-x","volume":"38","author":"HJ Wang","year":"2019","unstructured":"Wang HJ, Pochampalli M, Wang LY, Zou JX, Li PS, Hsu SC, Wang BJ, Huang SH, Yang P, Yang JC et al (2019) KDM8\/JMJD5 as a dual coactivator of AR and PKM2 integrates AR\/EZH2 network and tumor metabolism in CRPC. Oncogene 38:17\u201332","journal-title":"Oncogene"},{"key":"3167_CR70","doi-asserted-by":"crossref","unstructured":"Sheng W, LaFleur MW, Nguyen TH, Chen S, Chakravarthy A, Conway JR, Li Y, Chen H, Yang H, Hsu PH, et al (2018) LSD1 Ablation Stimulates Anti-tumor Immunity and Enables Checkpoint Blockade. Cell 174:549\u2013563 e519.","DOI":"10.1016\/j.cell.2018.05.052"},{"key":"3167_CR71","doi-asserted-by":"publisher","first-page":"9965099","DOI":"10.1155\/2021\/9965099","volume":"2021","author":"Y Wang","year":"2021","unstructured":"Wang Y, Cao K (2021) KDM1A Promotes Immunosuppression in Hepatocellular Carcinoma by Regulating PD-L1 through Demethylating MEF2D. J Immunol Res 2021:9965099","journal-title":"J Immunol Res"},{"key":"3167_CR72","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.canlet.2020.11.031","volume":"499","author":"J Yi","year":"2021","unstructured":"Yi J, Shi X, Xuan Z, Wu J (2021) Histone demethylase UTX\/KDM6A enhances tumor immune cell recruitment, promotes differentiation and suppresses medulloblastoma. Cancer Lett 499:188\u2013200","journal-title":"Cancer Lett"}],"container-title":["Cancer Immunology, Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03167-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00262-022-03167-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00262-022-03167-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,11]],"date-time":"2022-11-11T02:04:28Z","timestamp":1668132268000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00262-022-03167-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,7]]},"references-count":72,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["3167"],"URL":"https:\/\/doi.org\/10.1007\/s00262-022-03167-8","relation":{},"ISSN":["0340-7004","1432-0851"],"issn-type":[{"value":"0340-7004","type":"print"},{"value":"1432-0851","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,7]]},"assertion":[{"value":"14 November 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 March 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All the authors declare no competing conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study involving human samples was reviewed and approved by the Medical Ethics Committee of Wuhan University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}]}}